Jennifer J Rhodes insider trades

Open-market stock purchases and sales by Jennifer J Rhodes, EVP, CHIEF LEGAL OFFICER, SEC at Acadia Pharmaceuticals Inc, from SEC Form 4 filings since Jan 21, 2014.

Recent trades

DateStockTradeValue
Mar 25, 2026ACAD Acadia Pharmaceuticals IncSold$82.5K
Mar 24, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Feb 9, 2026ACAD Acadia Pharmaceuticals IncSold$162K
Feb 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—

Companies traded

  • ACAD Acadia Pharmaceuticals Inc: 2 sales, last Mar 25, 2026
  • ANGN Angion Biomedica Corp: 12 sales, last Mar 2, 2022
  • ADMS Adamas Pharmaceuticals Inc: 7 sales, last Jun 20, 2019
  • MDVN Medivation, Inc: 9 sales, last Mar 16, 2015

Get free alerts when Jennifer J Rhodes files a new trade →